Koninklijke Philips N.V. (ADR)
General ticker "PHG" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $24.3B (TTM average)
Koninklijke Philips N.V. (ADR) follows the US Stock Market performance with the rate: 64.7%.
Estimated limits based on current volatility of 1.8%: low 29.88$, high 30.88$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-13, amount 0.89$ (Y3.00%)
- Total employees count: 234000 as of 1998
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [23.69$, 36.23$]
- 2026-12-31 to 2027-12-31 estimated range: [26.17$, 39.59$]
Financial Metrics affecting the PHG estimates:
- Positive: with PPE of 15.4 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 7.98
- Positive: 19.40 < Shareholder equity ratio, % of 40.67 <= 42.68
- Negative: Investing cash flow per share per price, % of -3.35 <= -0.63
- Negative: Inventory ratio change, % of 6.18 > 0.80
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: Operating cash flow per share per price, % of 5.28 <= 6.64
Short-term PHG quotes
Long-term PHG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €18,169.00MM | €18,021.00MM | €17,834.00MM |
| Operating Expenses | €18,284.00MM | €17,492.00MM | €16,410.00MM |
| Operating Income | €-115.00MM | €529.00MM | €1,424.00MM |
| Non-Operating Income | €-412.00MM | €-406.00MM | €-242.00MM |
| Interest Expense | €306.00MM | €337.00MM | €332.34MM |
| R&D Expense | €1,890.00MM | €1,747.00MM | €1,700.00MM |
| Income(Loss) | €-527.00MM | €123.00MM | €1,182.00MM |
| Taxes | €-73.00MM | €963.00MM | €282.00MM |
| Profit(Loss)* | €-466.00MM | €-702.00MM | €895.00MM |
| Stockholders Equity | €12,028.00MM | €12,006.00MM | €10,957.00MM |
| Inventory | €3,491.00MM | €3,198.00MM | €2,870.00MM |
| Assets | €29,406.00MM | €28,976.00MM | €26,944.00MM |
| Operating Cash Flow | €2,309.26MM | €1,697.17MM | €1,162.00MM |
| Capital expenditure | €371.90MM | €342.90MM | €269.00MM |
| Investing Cash Flow | €-553.53MM | €-633.87MM | €-737.00MM |
| Financing Cash Flow | €-916.79MM | €-536.52MM | €107.00MM |
| Earnings Per Share** | €-0.49 | €-0.75 | €0.93 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.